Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 689-700

Bentham Science Publishers

Access to resources Recommend Favorite

Atypical Fibroxanthoma in the Setting of Chronic Lymphocytic Leukemia and Other Non-Hodgkin Lymphomas

By COLGAN MICHAEL B.   BREWER JERRY D.   WEAVER AMY L.   ROENIGK RANDALL K.   OTLEY CLARK C.  

Dermatologic Surgery, Vol. 37, Iss. 5, 2011-05 ,pp. : 671-676

Elsevier

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig   Lamanna Nicole   Weiss Mark A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth   Kahl Brad Steven  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia

By KHEZRI FARZANEH   BREWER JERRY D.   WEAVER AMY L.  

Dermatologic Surgery, Vol. 37, Iss. 8, 2011-08 ,pp. : 1100-1105

Elsevier

Access to resources Recommend Favorite